These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15817475)

  • 1. Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells.
    Chen D; Texada DE; Duggan C; Liang C; Reden TB; Kooragayala LM; Langford MP
    J Biol Chem; 2005 Jun; 280(23):22425-36. PubMed ID: 15817475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells.
    Chen D; Duggan C; Reden TB; Kooragayala LM; Texada DE; Langford MP
    Biochemistry; 2004 Sep; 43(37):11796-801. PubMed ID: 15362864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
    Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan.
    Wolfert MA; Murray TF; Boons GJ; Moore JN
    J Biol Chem; 2002 Oct; 277(42):39179-86. PubMed ID: 12151399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.
    Castellaneta A; Sumpter TL; Chen L; Tokita D; Thomson AW
    J Immunol; 2009 Dec; 183(11):6922-32. PubMed ID: 19890047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.
    Vidal VF; Castéran N; Riendeau CJ; Kornfeld H; Darcissac EC; Capron A; Bahr GM
    Eur J Immunol; 2001 Jul; 31(7):1962-71. PubMed ID: 11449348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
    Uehara A; Sugawara Y; Kurata S; Fujimoto Y; Fukase K; Kusumoto S; Satta Y; Sasano T; Sugawara S; Takada H
    Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of biologically active biotinylated muramyl dipeptides.
    Grimes CL; Podolsky DK; O'Shea EK
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6061-3. PubMed ID: 20822907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muramyl dipeptide activates human beta defensin 2 and pro-inflammatory mediators through Toll-like receptors and NLRP3 inflammasomes in human dental pulp cells.
    Lee SI; Kang SK; Jung HJ; Chun YH; Kwon YD; Kim EC
    Clin Oral Investig; 2015 Jul; 19(6):1419-28. PubMed ID: 25467233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
    Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
    Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
    Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
    J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.